合作者(3974)TOP 5
  • Thomas,GN
  • Critchley,JAJH
  • Hu,Miao
  • Chan,JCN
  • Chan,Paul
關 鍵 字
發文可能採用名字
  • Brian Tomlinson
  • Tomlinson, Brian
  • Tomlinson, B
  • 湯寧信
  • 汤宁信
  • Tomlinson, B.
  • Tomlinson B
  • Tomlinson B.
  • Tomlinson Brian
  • Tomlinson ,B.
  • Tomlinson B rian
  • Brian, Tomlinson
  • TOMLINSON, B

Brian Tomlinson

醫學院(FMD)

ORCID: 0000-0001-6717-5444

ResearcherID: AAD-9404-2019; P-5365-2015

成果: 764 件 | 合作者:3974 

WOS核心合集引用:15630 | H Index:60 | WOS收錄:598

CNKI收錄:15 | SCOPUS收錄:486

論文: 764

論文: 764 篇 上傳 編輯 糾錯 可能是Brian Tomlinson的文章 匯出

1.Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors

Tomlinson, Brian, Wu     More...

Journal of Lipid and Atherosclerosis[2287-2892], Published 2024, Volume 13, Issue 1, Pages 2-20

收錄情况: SCOPUS

2.Identification of a Common Variant for Coronary Heart Disease at PDE1A Contributes to Individualized Treatment Goals and Risk Stratification of Cardiovascular Complications in Chinese Patients With Type 2 Diabetes

Tam, Claudia H.T., L     More...

Diabetes care[1935-5548], Published 2023, Volume 46, Issue 6, Pages 1271-1281

收錄情况: WOS SCOPUS

WOS核心合集引用: 0 

3.Molecular mechanisms and therapeutic perspectives of peroxisome proliferator-activated receptor α agonists in cardiovascular health and disease

Pu, Yujie, Cheng, Ch     More...

Medicinal Research Reviews[0198-6325], Published 2023, Volume 43, Issue 6, Pages 2086-2114

收錄情况: WOS SCOPUS

WOS核心合集引用: 1  2022影響因子:  13.3 

4.Comparing the effectiveness and safety of dual antiplatelet with ticagrelor or clopidogrel in elderly Asian patients with acute myocardial infraction

Yeh, Jong Shiuan, Ch     More...

Frontiers in Cardiovascular Medicine[2297-055X], Published 2023, Volume 10,

收錄情况: WOS SCOPUS

WOS核心合集引用: 0  2022影響因子:  3.6 

5.What is the impact of type 2 diabetes mellitus on CYP450 metabolic activities?

Tomlinson, B, Li, YH

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2023, Volume 19, Issue 12, Pages 867-870

收錄情况: WOS SCOPUS

WOS核心合集引用: 0  2022影響因子:  4.3 

6.Canagliflozin plus metformin ER for the treatment of type 2 diabetes: the evidence to date

Tomlinson, B, Li, YH

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2023, Volume 24, Issue 18, Pages 1937-1947

收錄情况: WOS SCOPUS

WOS核心合集引用: 0  2022影響因子:  3.2 

7.DISTRIBUTIONS OF SERUM LIPOPROTEIN(A), LIPIDS AND APOLIPOPROTEINS AND IDENTIFICATION OF EXTREME VALUES SUGGESTING GENETIC LIPID DISORDERS IN CHINESE UNIVERSITY STUDENTS IN MACAU

Tomlinson, B, Lam, K     More...

ATHEROSCLEROSIS[0021-9150], Published 2023, Volume 379, Pages S53-S53

收錄情况: WOS

WOS核心合集引用: 0  2022影響因子:  5.3 

8.Endothelial Gata6 deletion reduces monocyte recruitment and proinflammatory macrophage formation and attenuates atherosclerosis through Cmpk2-Nlrp3 pathways (vol 64, 102775, 2023)

Wu, WR, Bao, WZ, Che     More...

REDOX BIOLOGY[2213-2317], Published 2023, Volume 66,

收錄情况: WOS

WOS核心合集引用: 0  2022影響因子:  11.4 

9.Case report: Distinctive cardiac features and phenotypic characteristics of Noonan syndrome with multiple lentigines among three generations in one family

Chan, CH, Chu, MF, L     More...

FRONTIERS IN CARDIOVASCULAR MEDICINE[2297-055X], Published 2023, Volume 10,

收錄情况: WOS SCOPUS

WOS核心合集引用: 0  2022影響因子:  3.6 

10.Endothelial Gata6 deletion reduces monocyte recruitment and proinflammatory macrophage formation and attenuates atherosclerosis through Cmpk2-Nlrp3 pathways

Wu, WR, Bao, WZ, Che     More...

REDOX BIOLOGY[2213-2317], Published 2023, Volume 64,

收錄情况: WOS SCOPUS

WOS核心合集引用: 2  2022影響因子:  11.4 

本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

Copyright © 2018 澳門科技大學學者庫